DNA methylation in lung cancer [4]

New England Journal of Medicine

Volumn 358, Issue 23, 2008, Pages 2514-

  Tezcan, Haluk ^a  

^a Kootenai Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; DNA METHYLATION; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; GENETIC MARKER; GENETICS; LUNG TUMOR; METASTASIS; NOTE; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 44849119432     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080541     Document Type: Letter

References (5)

1. S Mallal E Phillips G Carosi HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358 2008 568 579
2. S Hetherington S McGuirk G Powell Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 23 2001 1603 1614
3. EJ Phillips SA Mallal Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Curr Opin Infect Dis 21 2008 16 24
4. M Saag R Balu E Phillips High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis 46 2008 1111 1118
5. EJ Phillips Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet? Clin Infect Dis 43 2006 103 105